Volume 12, Issue 1 (11-2022)
aumj 2022, 12(1): 15-22 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Malek Mahdavi A, Khabbazi A. Serum Levels of Vitamin D in Patients With Palindromic Rheumatism and its Relationship with Clinical Characteristics. aumj 2022; 12 (1) :15-22
URL: http://aums.abzums.ac.ir/article-1-1619-en.html
URL: http://aums.abzums.ac.ir/article-1-1619-en.html
1- Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract: (1260 Views)
Background: Considering the clinical importance and remarkable prevalence of palindromic rheumatism and since there has been no study about serum vitamin D level in patients with palindromic rheumatism, therefore, present study designed to assess serum levels of vitamin D in patients with palindromic rheumatism and to analyze its relationship with clinical characteristics.
Methods: In present study, 39 patients aged ≥ 16 years with diagnosis of palindromic rheumatism and 81 healthy individuals without any history of inflammatory rheumatic diseases were selected from rheumatology outpatient clinic of Tabriz University of Medical Sciences during 2020-2021. Clinical status of patients was assessed by a rheumatologist and frequency of attacks, duration of attacks, number of involved joints, and duration of symptoms were recorded. Serum 25(OH) vitamin D3 levels were measured using a kit.
Results: Mean±SD serum 25(OH) vitamin D3 in patients and healthy subjects was 25.9±11.9 and 25.8±13.8 ng/mL, respectively (P=0.994). No significant relationship was observed between vitamin D deficiency and palindromic rheumatism (OR=0.39, 95%CI: 0.29-1.63, P=0.391). No significant correlation was observed between serum 25(OH)vitamin D3 and disease clinical characteristics including frequency of attacks, duration of attacks, number of involved joints, and duration of symptoms (P>0.05).
Conclusion: There was no significant relationship between vitamin D deficiency and occurrence of palindromic rheumatism as well as between serum 25(OH) vitamin D3 and clinical characteristics. It is suggested that further studies with larger sample size are performed to achieve concise conclusion about preventive and therapeutic approach regarding the relation between vitamin D and clinical status in patients with palindromic rheumatism.
Methods: In present study, 39 patients aged ≥ 16 years with diagnosis of palindromic rheumatism and 81 healthy individuals without any history of inflammatory rheumatic diseases were selected from rheumatology outpatient clinic of Tabriz University of Medical Sciences during 2020-2021. Clinical status of patients was assessed by a rheumatologist and frequency of attacks, duration of attacks, number of involved joints, and duration of symptoms were recorded. Serum 25(OH) vitamin D3 levels were measured using a kit.
Results: Mean±SD serum 25(OH) vitamin D3 in patients and healthy subjects was 25.9±11.9 and 25.8±13.8 ng/mL, respectively (P=0.994). No significant relationship was observed between vitamin D deficiency and palindromic rheumatism (OR=0.39, 95%CI: 0.29-1.63, P=0.391). No significant correlation was observed between serum 25(OH)vitamin D3 and disease clinical characteristics including frequency of attacks, duration of attacks, number of involved joints, and duration of symptoms (P>0.05).
Conclusion: There was no significant relationship between vitamin D deficiency and occurrence of palindromic rheumatism as well as between serum 25(OH) vitamin D3 and clinical characteristics. It is suggested that further studies with larger sample size are performed to achieve concise conclusion about preventive and therapeutic approach regarding the relation between vitamin D and clinical status in patients with palindromic rheumatism.
Type of Study: Research |
Subject:
Special
Received: 2022/10/24 | Accepted: 2022/11/01 | Published: 2022/11/01
Received: 2022/10/24 | Accepted: 2022/11/01 | Published: 2022/11/01
References
1. Khabbazi A, Hajialiloo M, Kolahi S, et al. A multicenter study of clinical and laboratory findings of palindromic rheumatism in Iran. International Journal of Rheumatic Diseases 2012; 15(4):427-430. [DOI:10.1111/j.1756-185X.2012.01739.x]
2. Iyer VR, Cohen GL. Palindromic rheumatism. Southern Medical Journal 2011; 104(2): 147-149. [DOI:10.1097/SMJ.0b013e318200c4cc]
3. Sanmartí R, Frade-Sosa B, Morl'a R, et al. Palindromic rheumatism: just a pre-rheumatoid stage or something else?. Frontiers in Medicine 2021; 8: 657983. [DOI:10.3389/fmed.2021.657983]
4. Charoenngam N, Shirvani A, Holick MF. Vitamin D for skeletal and non-skeletal health: What we should know. Journal of Clinical Orthopaedics and Trauma 2019; 10(6): 1082-1093. [DOI:10.1016/j.jcot.2019.07.004]
5. Martens PJ, Gysemans C, Verstuyf A, Mathieu C. Vitamin D's Effect on Immune Function. Nutrients 2020; 12(5): 1248. [DOI:10.3390/nu12051248]
6. Lemire JM, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive Actions of 1,25-Dihydroxyvitamin D3: Preferential Inhibition of Th1 Functions. Journal of Nutrition 1995; 125(6 Suppl): 1704S-1708S. [DOI:10.1016/0960-0760(95)00106-A]
7. Boonstra A, Barrat FJ, Crain C, et al. 1α,25-Dihydroxyvitamin D3 Has a Direct Effect on Naive CD4; T Cells to Enhance the Development of Th2 Cells. Journal of Immunology 2001; 167(9): 4974-4980. [DOI:10.4049/jimmunol.167.9.4974]
8. Kongsbak M, Levring TB, Geisler C, von Essen MR. The vitamin D receptor and T cell function. Frontiers in Immunology 2013; 4: 148. [DOI:10.3389/fimmu.2013.00148]
9. Rolf L, Muris AH, Hupperts R, Damoiseaux J. Illuminating vitamin D effects on B cells-The multiple sclerosis perspective. Immunology 2016; 147(3): 275-284. [DOI:10.1111/imm.12572]
10. Chen S, Sims GP, Chen XX, et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. Journal of Immunology 2007; 179(3): 1634-1647. [DOI:10.4049/jimmunol.179.3.1634]
11. Heine G, Niesner U, Chang HD, et al. 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. European Journal of Immunology 2008; 38(8): 2210-2218. [DOI:10.1002/eji.200838216]
12. Yamamoto EA, Nguyen JK, Liu J, et al. Low Levels of Vitamin D Promote Memory B Cells in Lupus. Nutrients 2020; 12(2): 291. [DOI:10.3390/nu12020291]
13. Infante M, Ricordi C, Sanchez J, et al. Influence of Vitamin D on Islet Autoimmunity and Beta-Cell Function in Type 1 Diabetes. Nutrients 2019; 11(9): 2185. [DOI:10.3390/nu11092185]
14. Hajjaj-Hassouni N, Mawani N, Allali F, et al. Evaluation of Vitamin D Status in Rheumatoid Arthritis and Its Association with Disease Activity across 15 Countries: "The COMORA Study". International Journal of Rheumatic Diseases 2017; 2017: 5491676. [DOI:10.1155/2017/5491676]
15. Islam MA, Khandker SS, Alam SS, et al. Vitamin D status in patients with systemic lupus erythematosus (SLE): A systematic review and meta-analysis. Autoimmunity Reviews 2019; 18(11): 102392. [DOI:10.1016/j.autrev.2019.102392]
16. Sahebari M, Nabavi N, Salehi M. Correlation between serum 25(OH)D values and lupus disease activity: An original article and a systematic review with meta-analysis focusing on serum VitD confounders. Lupus 2014; 23(11): 1164-1177. [DOI:10.1177/0961203314540966]
17. Khabbazi A, Rashtchizadeh N, Ghorbanihaghjo A, et al. The status of serum vitamin D in patients with active Behcet's disease compared with controls. International Journal of Rheumatic Diseases. 2014; 17(4): 430-434. [DOI:10.1111/1756-185X.12153]
18. Cai G, Wang L, Fan D, et al. Vitamin D in ankylosing spondylitis: review and meta-analysis. Clinica Chimica Acta 2015; 438: 316-322. [DOI:10.1016/j.cca.2014.08.040]
19. An L, Sun MH, Chen F, Li JR. Vitamin D levels in systemic sclerosis patients: A meta-analysis. Drug Design, Development and Therapy 2017; 11: 3119-3125. [DOI:10.2147/DDDT.S144860]
20. Alibaz-Oner F, Asmaz-Haliloglu Ö, Gogas-Yavuz D, et al. Vitamin D Levels in Takayasu's Arteritis and a Review of the Literature on Vasculitides. Journal of Clinical Laboratory Analysis. 2016; 30(5): 529-533. [DOI:10.1002/jcla.21898]
21. Munger KL, Levin LI, Hollis BW, et al. Serum25-hydroxyvitamin D levels and risk of multiple sclerosis. Journal of the American Medical Association 2006; 296(23):2832-2838. [DOI:10.1001/jama.296.23.2832]
22. Franco AS, Freitas TQ, Bernardo WM, Pereira RMR. Vitamin D supplementation and disease activity in patients with immune-mediated rheumatic diseases: A systematic review and meta-analysis. Medicine (Baltimore). 2017; 96(23): e7024. [DOI:10.1097/MD.0000000000007024]
23. Guerne PA, Weisman MH. Palindromic rheumatism: part of or apart from the spectrum of rheumatoid arthritis. The American Journal of Medicine. 1992; 93(4): 451-460 [DOI:10.1016/0002-9343(92)90177-D]
24. Kavoosi H, Kamali K, Gharibdoost F. Analysis of vitamin D levels in patients with rheumatoid arthritis and its relation with the disease status. Journal of Advances in Medical and Biomedical Research 2012; 20(78): 57-64.
25. Noroozi M, Gholamzadeh-Baeis M. The Serum Level of Vitamin D and its Association with Disease Severity in Patients with Rheumatoid Arthritis. Journal of Isfahan Medical School. 2017; 34(405): 1311-1317.
26. Yazmalar L, Ediz L, Alpayci M, et al. Seasonal disease activity and serum vitamin D levels in rheumatoid arthritis, ankylosing spondylitis and osteoarthritis. African Health Sciences 2013; 13(1): 47-55. [DOI:10.4314/ahs.v13i1.7]
27. Sahebari M, Mirfeizi Z, Rezaieyazdi Z, et al. 25(OH) vitamin D serum values and rheumatoid arthritis disease activity (DA S28 ESR). Caspian Journal of Internal Medicine 2014; 5(3): 148-155.
28. Costenbader KH, Feskanich D, Holmes M, et al. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Annals of the Rheumatic Diseases 2008; 67(4): 530-535. [DOI:10.1136/ard.2007.072736]
29. Borukar SC, Chogle AR, Deo SS. Relationship between Serum 25-Hydroxyvitamin D Levels, Disease Activity and Anti-Cyclic Citrullinated Peptide Antibody Levels in Indian Rheumatoid Arthritis Patients. Journal of Rheumatic Diseases and Treatment 2017; 3(3): 056. [DOI:10.23937/2469-5726/1510056]
30. Durmus B, Altay Z, Baysal O, Ersoy Y. Does vitamin D affect disease severity in patients with ankylosing spondylitis?. Chinese Medical Journal 2012; 125 (14): 2511-2515.
31. Elamir A, Ibrahim T, Fouad NA, Masoud M. Serum Vitamin D levels in Rheumatoid arthritis and Relationship with disease activity. 2022; 38(2): 175-184. [DOI:10.21608/besps.2018.8206]
32. Turhanoglu AD, Guler H, Yonden Z, et al. The relationship between vitamin D and disease activity and functional health status in rheumatoid arthritis. Rheumatology International 2011; 31(7): 911-914. [DOI:10.1007/s00296-010-1393-6]
33. Esalatmanesh K, Taghadosi M, Arj A, et al. Relevance of serum vitamin D level and the disease activity in rheumatoid arthritis. Feyz, Journal of Kashan University of Medical Sciences 2011; 14(4): 414-419.
34. Mermerci BB, Pekin DY, Sivas F, et al, The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis. Rheumatology International 2010; 30(3): 375-381. [DOI:10.1007/s00296-009-0975-7]
35. Kolahi S, Khabbazi A, Kazemi N, Malek Mahdavi A. Does vitamin D deficiency contribute to higher disease activity in patients with spondyloarthritis?. Immunology Letters 2019; 212: 1-5. [DOI:10.1016/j.imlet.2019.06.005]
36. Erten S, Kucuksahin O, Sahin A, et al. Decreased plasma vitamin D levels in patients with undifferentiated spondyloarthritis and ankylosing spondylitis. Internal Medicine 2013; 52(3): 339-344. [DOI:10.2169/internalmedicine.52.9047]
37. Lange U, Teichmann J, Strunk J, et al. Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporosis International 2005; 16(12): 1999-2004. [DOI:10.1007/s00198-005-1990-5]
38. Arends S, Spoorenberg A, Bruyn GA, et al. The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a crosssectional analysis. Osteoporosis International 2011; 22(5): 1431-1439. [DOI:10.1007/s00198-010-1338-7]
39. Guła Z, Kopczyńska A, Hańska K, et al. Vitamin D serum concentration is not related to the activity of spondyloarthritis- preliminary study. Reumatologia 2018; 56(6): 388-391. [DOI:10.5114/reum.2018.80717]
40. Hajialilo M, Noorabadi P, Tahsini Tekantapeh S, Malek Mahdavi A. Endothelin‑1, α‑Klotho, 25(OH) Vit D levels and severity of disease in scleroderma patients. Rheumatology International 2017; 37(10): 1651-1657. [DOI:10.1007/s00296-017-3797-z]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
